Cheryl Proctor
Family · Raleigh, NCNPI 1942324645
Payments from drug & device makers
Across 76 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$296
- AbbVie$257
- Lilly USA, LLC$140
- AstraZeneca$115
- Exact Sciences$89
- Pfizer$86
- plus $409 from 14 others
What the payments were for
- Food & beverage$1,392100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $296 |
| AbbVie | 14 | $257 |
| Lilly USA, LLC | 7 | $140 |
| AstraZeneca | 6 | $115 |
| Exact Sciences | 5 | $89 |
| Pfizer | 5 | $86 |
| Amgen | 3 | $57 |
| Boehringer Ingelheim | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Abbott | 2 | $36 |
| Dexcom, Inc. | 2 | $35 |
| Noctrix Health, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| GSK | 1 | $17 |
| Abiomed | 1 | $16 |
| Merck | 1 | $16 |
| Sonex Health, Inc. | 1 | $15 |
How this compares
$1,392 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $16,851 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 69 | $15,432 |
| Adacel TdapDiph,pertuss(Acell),tet Vac/Pf | 87 | $6,116 |
| Rosuvastatin Calcium | 18 | $230 |
| Levothyroxine Sodium | 26 | $117 |
| Atorvastatin Calcium | 13 | $78 |
| Amlodipine Besylate | 12 | $61 |
| Diazepam | 11 | $46 |
| Alprazolam | 18 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $296 | $16,85118 claims |
| GSKShingrix | $17 | $15,43269 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.
Other family in Raleigh
- Michele CerraRaleigh$332K
- Carrie PettitRaleigh$298K
- Jennifer GibbsRaleigh$216K
- Holly StarnesRaleigh$69K
- Harry LayRaleigh$63K
- Lauren HendricksRaleigh$17K
- Margaretann HouseRaleigh$16K
- Gretchen ReichmannRaleigh$13K
- Leslie ByrneFayetteville$482K
- Anne LakeArchdale$306K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.